ARCHIVES

DCT Advisors Approve Five Trials For High Priority Status

This article is from The Cancer Letter archive.

Vol. 21 No. 14 | April 7, 1995

Download PDF Visit The Full Archive

Related Articles

OMB Specifies One Year Only Funding for 200 grants Under Supplemental Appropriations Level of 6,200

September 6, 1985

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004

DOD To Reimburse Care On Clinical Trials In Three-Year Deal

February 9, 1996

NCI Formaldehyde Finding Criticized

March 7, 1986

New Cancer Survival, Incidence, Mortality Statistics Cause for Optimism, Concern

February 12, 1988

Cancer Genome Atlas Researchers Link Cell Metabolism Pathways To Disease Aggressiveness

July 26, 2013